All News PT Kalbe Farma Tbk.

Equities

KLBF

ID1000125107

End-of-day quote INDONESIA S.E. Other stock markets 03:30:00 26/06/2024 am IST			5-day change	1st Jan Change
1,535 ^IDR	+0.66%		-1.29%	-4.66%

17/05	Nomura Adjusts Kalbe Farma’s Price Target to 1,900 Rupiahs From 1,850 Rupiahs, Keeps at Buy	MT
30/04	PT Kalbe Farma Tbk. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

PT Kalbe Farma Tbk : Kalbe to Buy Back Shares of Rp1 trillion	29/05	PU
Ex-dividend day for final dividend	29/05	FA
Nomura Adjusts Kalbe Farma’s Price Target to 1,900 Rupiahs From 1,850 Rupiahs, Keeps at Buy	17/05	MT
PT Kalbe Farma Tbk : Company Update - Q1 2024 Unaudited Results (02-May-2024)	02/05	PU
PT Kalbe Farma Tbk. Reports Earnings Results for the First Quarter Ended March 31, 2024	30/04	CI
PT Kalbe Farma Tbk. Reports Earnings Results for the Full Year Ended December 31, 2023	01/04	CI
Nomura Adjusts Kalbe Farma’s Price Target to IDR1,850 From IDR2,500, Keeps at Buy	20/02	MT
PT Kalbe Farma Tbk. Reports Earnings Results for the Nine Months Ended September 30, 2023	31/23/31	CI
Genexine and KGbio received the first market approval for novel long-acting Erythropoietin, Efepoetin alfa, from The Indonesian Food and Drug Authority (BPOM)	23/23/23	BU
Henlius Expands Collaboration with KGbio to Develop, Commercialize and Supply Henlius novel anti-PD-1 mAb HANSIZHUANG in MENA	13/23/13	AQ
PT Kalbe Farma Tbk : KIMIA FARMA & KALBE FARMA COLLABORATED TO IMPROVE HEALTH SERVICES FOR THE SOCIETY	01/23/01	PU
PT Kalbe Farma Tbk. Reports Earnings Results for the Half Year Ended June 30, 2023	07/23/07	CI
PT Kalbe Farma Tbk : KALBE INTRODUCES MESOTHERAPY PRODUCTS IN AESTHETIC TREATMENT	17/23/17	PU
PT Kalbe Farma Tbk : KALBE INTRODUCES AUTOIMMUNE DISEASES FURTHER	08/23/08	PU
Ex-dividend day for final dividend	12/23/12	FA
PT Kalbe Farma Tbk : Kalbe Announced Dividend of 52% from Net Profit	04/23/04	PU
PT Kalbe Farma Tbk : 2022, Recover Together for Healthier Nation	02/23/02	PU
PT Kalbe Farma Tbk : Kalbe Maintained Double Digit Top Line Growth in the First Quarter of 2023	28/23/28	PU
PT Kalbe Farma Tbk : Company Update - Q1 2023 Unaudited Results (28-April-2023)	28/23/28	PU
PT Kalbe Farma Tbk. Reports Earnings Results for the First Quarter Ended March 31, 2023	28/23/28	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News PT Kalbe Farma Tbk.

Equities

KLBF

ID1000125107

All News

Filters